https://clinicaltrials.gov/ct2/show/NCT03954600?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F03%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Phase 1 Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects
DESCRIPTION:
Condition: Healthy Volunteers
Interventions: Drug: NPT520-34 (125 mg); Drug: Placebos (125 mg)
Sponsors: Neuropore Therapies Inc.; Celerion
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03954600
FIRST POSTED:
Fri, 17 May 2019 12:00:00 EDT
LAST UPDATE POSTED:
05/17/19 07:09AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03954600?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F03%2F2019&lupd_d=14&sort=nwst